$NOK

Here are Tuesday's biggest analyst calls: Nvidia, Apple, AMD, Etsy, Eli Lilly, Samsara & more

Analysts made several calls on Tuesday, including upgrades for Nokia (NOK), The New York Times (NYT), Agilon (AGL), and Eli Lilly (LLY). Price targets were raised for NYT ($82), AGL ($125), and Palantir (PLTR, $250). Other notable actions include initiations on Janus Living, Vishay Intertechnology (VSH), and Samsara (IOT).

Original reporting
Published Sep 15, 2026, 2:00 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Sep 15, 2026, 2:22 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
Here are Tuesday's biggest analyst calls: Nvidia, Apple, AMD, Etsy, Eli Lilly, Samsara & more — source image
Decision brief

The 30-second read

$NOKBullishMed
01

Why it matters

The collective upgrades provide short‑term buying opportunities but lack deep fundamental catalysts, suggesting limited durability.

02

Market read

Analyst sentiment broadly positive, especially for AI‑related and tech stocks, potentially supporting market breadth.

03

What to watch

Many upgrades lack underlying earnings data; price targets may be optimistic.

Relevance 6/10Novelty 6/10Timing: today

Background

Analyst houses released a series of upgrades, initiations, and target revisions across multiple sectors.

Company-level read

Ticker impact

$NOKBullishMedium confidence
Context

Rosenblatt initiates Nokia as buy, citing AI infrastructure positioning.

Expected impact

Modest upside as investors absorb upgrade.

Evidence & confidence

Buy initiation with target suggests ~20% upside.

$NYTBullishMedium confidence
Context

Guggenheim upgrades The New York Times Company to buy with new price target.

Expected impact

Short‑term rally expected.

Evidence & confidence

Buy rating and 20% upside target provide clear catalyst.

$AGLBullishMedium confidence
Context

Bernstein upgrades Agilon Health to outperform, raising target to $125.

Expected impact

Potential modest upside.

Evidence & confidence

Target increase reflects better outlook.

$VSHBullishMedium confidence
Context

Oppenheimer initiates Vishay Intertechnology as outperform with $42 PT.

Expected impact

Potential short‑term rally.

Evidence & confidence

Initiation and PT imply upside.

$NOCBullishMedium confidence
Context

Guggenheim initiates Northrop Grumman as buy, citing unique capabilities.

Expected impact

Modest upside.

Evidence & confidence

Defense sector upgrade often supportive.

$BSYBullishMedium confidence
Context

Cantor Fitzgerald initiates Bentley Systems as overweight.

Expected impact

Potential rally.

Evidence & confidence

Weight increase signals confidence.

$ULTANeutralLow confidence
Context

Wells Fargo upgrades Ulta to equal weight from underweight.

Expected impact

Limited impact.

Evidence & confidence

Equal weight is a modest change.

$IOTBullishMedium confidence
Context

Cantor Fitzgerald initiates Samsara as overweight, highlighting IoT moat.

Expected impact

Potential upside.

Evidence & confidence

Strong thesis on market position.

Market effects

Broad analyst upgrades lift tech, healthcare, and industrial sectors.

US equity sentiment reinforced, especially AI‑related names.

Limited to US‑listed companies; no direct global macro effect.

Counterpoint

Upgrades may be premature if earnings miss expectations later.

Key entities

  • Rosenblatt

    Initiated Nokia as buy.

  • Guggenheim

    Upgraded NYT and initiated NOC.

  • Bank of America

    Reiterated buy on NVDA, MRVL, AMD.

Related articles

$LLYLow

Nektar v. Lilly: Lilly Defeats CRE Claim, But Jury Finds It Owes $90M For Breaching The Implied Covenant Of Good Faith And Fair Dealing

A federal jury ruled that Eli Lilly & Co. breached the implied covenant of good faith and fair dealing with Nektar Therapeutics, awarding Nektar $90 million in damages. The jury rejected Nektar's claim that Lilly breached the license agreement's commercially reasonable efforts (CRE) obligation. Lilly plans to appeal, arguing no liability should have been imposed. The case highlights risks in biopharma licensing agreements.

Big AI ambitions, cautious lenders: Naver’s $10b financing test

Naver and Brookfield are negotiating up to $9 billion in financing for the first phase of Naver's Gak Sejong AI data center expansion, which aims to increase capacity to 200 MW. The project requires significant investment in GPUs, complicating lenders' assessments of its commercial viability. Nvidia plans to invest $1 billion, and several Korean banks and securities firms are considering participation. The project's success could set a precedent for future AI infrastructure financing.

$NVDAMed

NVIDIA DGX Station for Windows: 748GB, 20 PFLOPs

NVIDIA launched DGX Station for Windows, a desktop AI system with 748GB memory and 20 petaFLOPs compute, using the GB300 Grace Blackwell Ultra Superchip. It targets enterprise developers, offering Windows compatibility while maintaining Linux version's specs. The system supports trillion-parameter models and optional RTX PRO 6000 GPU. Availability is expected in Q4 2026.